Sana Biotechnology Stock Performance
| SANA Stock | USD 4.63 0.18 4.04% |
Sana Biotechnology holds a performance score of 22 on a scale of zero to a hundred. The entity has a beta of 1.6, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Sana Biotechnology will likely underperform. Use Sana Biotechnology expected short fall, day median price, and the relationship between the potential upside and accumulation distribution , to analyze future returns on Sana Biotechnology.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Sana Biotechnology are ranked lower than 22 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Sana Biotechnology sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 4.04 | Five Day Return 10.5 | Year To Date Return 180.61 | Ten Year Return (86.81) | All Time Return (86.81) |
1 | Levi Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2025 in Sana ... | 05/05/2025 |
2 | May 20, 2025 Deadline Contact Levi Korsinsky to Join Class Action Suit Against SANA | 05/13/2025 |
3 | SANA DEADLINE TOMORROW ROSEN, LEADING INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important May 20 Deadline in Secu... | 05/19/2025 |
4 | Sana Biotechnology to Present at June 2025 Investor Conferences SANA Stock News | 05/28/2025 |
5 | Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes ... | 06/09/2025 |
6 | SANA Announces Promising Results from Diabetes Cell Therapy Study SANA Stock News | 06/23/2025 |
7 | SANA JMP Securities Reiterates Market Outperform Rating SANA Stock News | 06/24/2025 |
8 | Morgan Stanley initiates Sana Biotechnology stock with Overweight rating By Investing.com - Investing.com Nigeria | 07/02/2025 |
9 | Acquisition by Bishop Hans Edgar of 7842 shares of Sana Biotechnology subject to Rule 16b-3 | 07/07/2025 |
10 | Acquisition by Hordo Christian of 168750 shares of Sana Biotechnology at 9.58 subject to Rule 16b-3 | 07/10/2025 |
11 | What drives Sana Biotechnology Inc. stock price - Superior stock selection - Jammu Links News | 07/18/2025 |
| Begin Period Cash Flow | 137.3 M | |
| Total Cashflows From Investing Activities | 17.5 M |
Sana Biotechnology Relative Risk vs. Return Landscape
If you would invest 159.00 in Sana Biotechnology on April 21, 2025 and sell it today you would earn a total of 304.00 from holding Sana Biotechnology or generate 191.19% return on investment over 90 days. Sana Biotechnology is currently generating 1.9147% in daily expected returns and assumes 6.6667% risk (volatility on return distribution) over the 90 days horizon. In different words, 59% of stocks are less volatile than Sana, and 62% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Sana Biotechnology Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sana Biotechnology's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Sana Biotechnology, and traders can use it to determine the average amount a Sana Biotechnology's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2872
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | SANA | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.67 actual daily | 59 59% of assets are less volatile |
Expected Return
| 1.91 actual daily | 38 62% of assets have higher returns |
Risk-Adjusted Return
| 0.29 actual daily | 22 78% of assets perform better |
Based on monthly moving average Sana Biotechnology is performing at about 22% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sana Biotechnology by adding it to a well-diversified portfolio.
Sana Biotechnology Fundamentals Growth
Sana Stock prices reflect investors' perceptions of the future prospects and financial health of Sana Biotechnology, and Sana Biotechnology fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Sana Stock performance.
| Return On Equity | -0.71 | ||||
| Return On Asset | -0.24 | ||||
| Current Valuation | 1.03 B | ||||
| Shares Outstanding | 225.56 M | ||||
| Price To Book | 4.99 X | ||||
| EBITDA | (251.27 M) | ||||
| Net Income | (266.76 M) | ||||
| Cash And Equivalents | 484.8 M | ||||
| Cash Per Share | 2.57 X | ||||
| Total Debt | 94.2 M | ||||
| Debt To Equity | 0.18 % | ||||
| Current Ratio | 5.09 X | ||||
| Book Value Per Share | 0.93 X | ||||
| Cash Flow From Operations | (223.15 M) | ||||
| Earnings Per Share | (0.88) X | ||||
| Market Capitalization | 1.04 B | ||||
| Total Asset | 501.02 M | ||||
| Retained Earnings | (1.6 B) | ||||
| Working Capital | 115.38 M | ||||
About Sana Biotechnology Performance
By analyzing Sana Biotechnology's fundamental ratios, stakeholders can gain valuable insights into Sana Biotechnology's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Sana Biotechnology has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Sana Biotechnology has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.89) | (0.93) | |
| Return On Capital Employed | (0.60) | (0.63) | |
| Return On Assets | (0.53) | (0.56) | |
| Return On Equity | (1.06) | (1.01) |
Things to note about Sana Biotechnology performance evaluation
Checking the ongoing alerts about Sana Biotechnology for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Sana Biotechnology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Sana Biotechnology is way too risky over 90 days horizon | |
| Sana Biotechnology appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (266.76 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Sana Biotechnology currently holds about 484.8 M in cash with (223.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.57. | |
| Sana Biotechnology has a frail financial position based on the latest SEC disclosures | |
| Over 89.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: What drives Sana Biotechnology Inc. stock price - Superior stock selection - Jammu Links News |
- Analyzing Sana Biotechnology's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Sana Biotechnology's stock is overvalued or undervalued compared to its peers.
- Examining Sana Biotechnology's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Sana Biotechnology's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Sana Biotechnology's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Sana Biotechnology's stock. These opinions can provide insight into Sana Biotechnology's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Sana Stock analysis
When running Sana Biotechnology's price analysis, check to measure Sana Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sana Biotechnology is operating at the current time. Most of Sana Biotechnology's value examination focuses on studying past and present price action to predict the probability of Sana Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sana Biotechnology's price. Additionally, you may evaluate how the addition of Sana Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |